ABSTRACT
The trade conflicts that the EU has faced within the EU or WTO context demonstrate that the question of how to balance trade and other societal values in situations of uncertainty has not been solved by the regulatory model evolved by the EU in the aftermath of the BSE crisis – one which privileges processes of depoliticisation and scientification. This book addresses the current key dilemmas around science, law and the regulation of trade, both on a regime level and in the context of particular industrial sectors, e.g pharmaceuticals, climate change and nanotechnology. It will present possible future research avenues by looking at both theory and practice and learning from various disciplines (law and social sciences), legal realities (WTO, USA and EU) and actors (regulators, stakeholders, courts).
TABLE OF CONTENTS
part I|21 pages
Introduction and conclusion
part II|66 pages
Science and precaution in regulatory decision-making
chapter 2|27 pages
Science and decision-making
chapter 3|15 pages
Between uncertainty and responsibility
part III|69 pages
Regulatory practice: Pharmaceuticals, nanotechnology and climate change
chapter 4|22 pages
Handling pharmaceutical risks in post-trust society
chapter 5|20 pages
Responsive governance of uncertain risks in the European Union
chapter 6|25 pages
Climate change, targets and trade
part IV|74 pages
Role of courts
chapter 7|52 pages
The role of science in mediating the conflict between free trade and health regulation at the WTO
part V|25 pages
Role of stakeholders